Fisetin for COVID‐19 in skilled nursing facilities: Senolytic trials in the COVID era

The burden of senescent cells (SnCs), which do not divide but are metabolically active and resistant to death by apoptosis, is increased in older adults and those with chronic diseases. These individuals are also at the greatest risk for morbidity and mortality from SARS‐CoV‐2 infection. SARS‐CoV‐2...

Descripción completa

Detalles Bibliográficos
Autores principales: Verdoorn, Brandon P., Evans, Tamara K., Hanson, Gregory J., Zhu, Yi, Langhi Prata, Larissa G. P., Pignolo, Robert J., Atkinson, Elizabeth J., Wissler‐Gerdes, Erin O., Kuchel, George A., Mannick, Joan B., Kritchevsky, Stephen B., Khosla, Sundeep, Rizza, Stacey A., Walston, Jeremy D., Musi, Nicolas, Lipsitz, Lewis A., Kiel, Douglas P., Yung, Raymond, LeBrasseur, Nathan K., Singh, Ravinder J., McCarthy, Teresa, Puskarich, Michael A., Niedernhofer, Laura J., Robbins, Paul D., Sorenson, Matthew, Tchkonia, Tamara, Kirkland, James L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
COVID‐19‐Related Content
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447437/
https://www.ncbi.nlm.nih.gov/pubmed/34375437
http://dx.doi.org/10.1111/jgs.17416

Ejemplares similares

Ejemplares similares